Current practice of launching sequentially new drugs on the global market is forgoing the pharma business hundreds of millions of dollars.

OGP - Optimal Global Pricing technology is solving this problems. OGP enables a pricing function which is paralleling the drug development process. When the drug is ready to be launched the regulatory agencies have already seen/approved global pricing structure all along and the price negotiations with individual markets are cut short.